US FDA grants clearance for the use of Verdeca’s HB4 stress-tolerant soybeans in human food

8cbd8b5a-716e-45e1-8dc2-75e602e028c8articleimage.jpg

11 Aug 2017 --- Arcadia Biosciences Inc. and Bioceres S.A. have announced that the US Food and Drug Administration (FDA) has completed its full review of the safety evaluation for HB4 soybeans, produced by their joint venture, Verdeca. The FDA’s notice to Verdeca allows products derived from HB4 soybeans to be used commercially in human food and animal feed. 

The US FDA uses its Biotechnology Notice process to review and assess safety data provided by companies developing new plant varieties using advanced breeding technologies. The data provided to the FDA is consistent with international regulatory requirements for genetically modified crops and will be used by Verdeca and its global partners for future regulatory submissions, the companies report.

Verdeca’s HB4 soybeans have undergone extensive testing, including multi-location field trials in Argentina and the US and multiple regulatory field trials. The results of these trials demonstrate that the HB4 trait can provide yield advantages under stress conditions – including drought and low-water conditions – found in several soybean production areas.

“The HB4 gene holds great promise for bringing better yield stability to agriculture in areas that experience chronic water stress problems,” says Raj Ketkar, President and CEO of Arcadia Biosciences. “Our combined efforts aim to create significant value for soybean growers by increasing the productivity and sustainability of this important protein crop in the face of global climate challenges.”

“The FDA is one of the most prestigious regulatory agencies in the world, and its opinions are of reference to regulators everywhere,” says Federico Trucco, CEO of Bioceres. “In a way, this FDA clearance testifies to the quality standards implemented in HB4 product development and safety evaluations. We hope this decision will help expedite international regulatory clearances for HB4 soybeans, and bring us closer to the much-anticipated launch of this unique technology.”

Completion of the FDA’s review is another key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The trait has already been approved in Argentina by the Ministry of Agriculture, Livestock and Fisheries.

Related Articles

Nutrition & Health News

Food for the heart (Part 2): Consumer trends and innovations

19 Oct 2017 --- Food for heart health is a key trend in nutrition NPD, with many companies exploring ways in which to protect consumers against cardiovascular issues. Today, in the second part of a special report, NutritionInsight examines which consumer trends are driving innovation in the world of heart health products and what these innovations are.

Nutrition & Health News

Latest boost for plant-based protein as Quorn products show muscle benefits

12 Oct 2017 --- Protein found in Quorn meat-free foods may be just as beneficial for muscles as animal proteins, new research funded by Quorn Foods suggests. News of the successful study is the latest to highlight a rosy future for plant-based proteins in the food and beverage marketplace.

Nutrition & Health News

DuPont soybean oil causes less obesity and insulin resistance, but may harm liver: study

06 Oct 2017 --- Researchers at the University of California, Riverside have found that while a genetically-modified (GM) soybean oil used in many restaurants induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil.

Food Ingredients News

DuPont Nutrition & Health debuts new plant-based, 90 percent protein nuggets

28 Sep 2017 --- DuPont Nutrition & Health has expanded its 90 percent protein nugget product range, with three new products which have an exceptionally high level of protein and are label friendly. These plant-based nuggets have a neutral flavor and crispy, crunchy texture and are ideal for use in snacks, cereals and nutrition bars, DuPont reports. 

Business News

Milk-alternative drinks shown to be short on iodine

26 Sep 2017 --- Consumers of milk-alternative drinks may be at risk of iodine deficiency, according to the findings of the first study of its kind in the UK, published in the British Journal of Nutrition. This may prove to be another potential marketing platform for the dairy industry following the recent European Court of Justice ruling that purely plant-based products cannot be marketed with names like “milk.”

More Articles
URL : http://www.nutritioninsight.com:80/news/US-FDA-grants-clearance-for-the-use-of-Verdecas-HB4-stress-tolerant-soybeans-in-human-food.html